1L
PFE icon

10Elms LLP’s Pfizer PFE Stock Holding History

10Elms LLP’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.9K Buy
700
+200
+40% +$5.23K 0.01% 395
2026
Q1 		$14K Hold
500
– – 0.01% 383
2025
Q4 		$12.4K Sell
500
-200
-29% -$5.04K 0.01% 373
2025
Q3 		$17.8K Hold
700
– – 0.02% 358
2025
Q2 		$17K Hold
700
– – 0.02% 362
2025
Q1 		$17.7K Sell
700
-1,913
-73% -$50.1K 0.02% 364
2024
Q4 		$69.3K Buy
+2,613
New +$70.9K 0.07% 164

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

10Elms LLP's PFE Position: Q2 2026 in Review

10Elms LLP increased its Pfizer (PFE) stake by 40% in Q2 2026, buying an estimated $5.23K and bringing the position to 700 shares worth $16.9K. The position accounts for 0.01% of the portfolio, ranked #395.

10Elms LLP first reported a position in PFE in Q4 2024 and has held it in 7 quarters since. The position peaked at $69.3K in Q4 2024. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • 10Elms LLP held 700 shares of Pfizer worth $16.9K as of Q2 2026.
  • 10Elms LLP bought 200 Pfizer shares in Q2 2026, an estimated $5.23K.
  • Pfizer made up 0.01% of 10Elms LLP's portfolio in Q2 2026, its #395 holding.
  • 10Elms LLP first reported a position in Pfizer in Q4 2024 and has held it in 7 quarters since.
  • 10Elms LLP's Pfizer position peaked at $69.3K in Q4 2024.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on 10Elms LLP's 13F filing for Q2 2026, filed 14 Aug 2026.